In Parallel

In Parallel is an execution intelligence company focused on helping senior leaders in Pharma and Biotech turn portfolio complexity into decisive action. We work with organizations running large, multi-program portfolios where strategy, execution, and governance drift apart — not because of lack of tools, but because insight arrives too late or in fragmented form. In Parallel transforms everyday execution signals (meetings, portfolio updates, decisions, risks) into a continuously updated, decision-ready execution view. Our platform is designed for Portfolio, Program, and Project Management leaders operating in regulated, matrixed environments. Instead of adding another reporting layer, In Parallel connects directly to the moments where execution reality is created — portfolio reviews, governance meetings, cross-functional syncs — and converts them into structured insights, risks, commitments, and plan changes with full ownership and auditability. This allows PPM leaders to move from reactive reporting to proactive portfolio steering. In Parallel is perfectly suited for enterprise pharma and biotech organizations managing R&D pipelines, transformation programs, and complex delivery portfolios. We help PPM leaders reduce decision latency, improve governance quality, and maintain a single, trusted execution narrative across functions, geographies, and leadership levels — without increasing administrative burden on teams.